Repurposing Fenofibrate in Modulating mTOR/NLRP3 Inflammasome in Patients With Ulcerative Colitis
Condition: Inflammatory Bowel Diseases Interventions: Drug: Mesalamine; Drug: Fenofibrate Sponsors: Tanta University; Eman Ibrahim Elberri, Faculty of Pharmacy, Tanta University; Fedaa Abd El-monem Kamal El-deen Kotkata Faculty of Pharmacy, Tanta University; Manal Ali Mahrous Hamouda Faculty of Pharmacy, Menufia University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Asacol | Fenofibrate | Inflammatory Bowel Disease | Lialda | Men | Research | Tricor | Ulcerative Colitis